Fulvestrant and everolimus efficacy after CDK4/6 inhibitor: a prospective study with circulating tumor DNA analysis

Oncogene, Published online: 27 February 2024; doi:10.1038/s41388-024-02986-6Fulvestrant and everolimus efficacy after CDK4/6 inhibitor: a prospective study with circulating tumor DNA analysis

https://www.nature.com/articles/s41388-024-02986-6

Source: Oncogene - February 27, 2024 Category: Cancer & Oncology Authors: Antoine Vasseur Luc Cabel Caroline Hego Wissam Takka Olfa Trabelsi Grati Benjamin Renouf Florence Lerebours Delphine Loirat Etienne Brain Paul Cottu Marie-Paule Sablin Jean-Yves Pierga C éline Callens Shufang Renault Fran çois-Clément Bidard Source Type: research